臨床試驗

Coating to Optimize Aneurysm Treatment In The New Flow Diverter Generation

NCT：NCT04870047 · COMPLETED

NCT IDNCT04870047

狀態COMPLETED

開始日期2021-09-03

完成時間2025-12-12

SponsorPhenox GmbH (INDUSTRY)

First posted2021-05-03

Last updated2026-09-18

簡要摘要

To assess safety and efficacy of p64 MW HPC Flow Modulation Device under single antiplatelet therapy compared to p64 MW Flow Modulation Device under dual antiplatelet therapy.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。